C-Reactive Protein

Patients with rheumatoid arthritis who have lower disease activity are more likely to remain in remission after switching from combination therapy to monotherapy, according to data published in The Journal of Rheumatology.

Published results showed plasma D-dimer was noninferior to serum C-reactive protein and erythrocyte sedimentation rate in the diagnosis of periprosthetic joint infection.

A novel agent demonstrated a dose-dependent relationship with lectin-like oxidized LDL receptor-1 suppression, a mechanism to lower inflammatory and lipid risk, and was well tolerated in a small study of patients with type 2 diabetes.

Higher prenatal C-reactive protein levels and increases in these levels from early to late pregnancy were associated with childhood asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Results presented at the Musculoskeletal Infection Society Annual Meeting showed synovial biomarkers did not demonstrate high prognostic utility for predicting failure following reimplantation.

In diagnosing periprosthetic joint infection during two-stage exchange, results showed C-reactive protein had the highest diagnostic utility, while erythrocyte sedimentation rate and synovial biomarkers had acceptable diagnostic utility.

Anti-inflammatory medications like steroids at hospital discharge may reduce post-acute infection mortality risk in patients who experienced hyperinflammation from severe COVID-19, according to data published in Frontiers in Medicine.

Compared with those who never had student debt or repaid it, adults who consistently had student debt or took on new debt had elevated risk for CVD and high C-reactive protein levels in early midlife, researchers reported.

Older age and high C-reactive protein were associated with an increased risk for death among people with diabetes hospitalized with COVID-19 in one region of England, according to a speaker.

The C-reactive protein and alpha-fetoprotein in immunotherapy score identified patients with favorable hepatocellular carcinoma disease control and survival, according to a study presented at the International Liver Congress.